NLRP3 and cryopyrin-associated periodic syndrome: PKD inhibition with the specific inhibitor CRT 0066101 led to reduced NLRP3 inflammasome activity in LPS-stimulated peripheral blood mononuclear cells (PBMCs) isolated from CAPS patients [66].